首页> 外文期刊>Malaria research and treatment >AdditiveIn VitroAntiplasmodial Effect ofN-Alkyl andN-Benzyl-1,10-Phenanthroline Derivatives and Cysteine Protease Inhibitor E64
【24h】

AdditiveIn VitroAntiplasmodial Effect ofN-Alkyl andN-Benzyl-1,10-Phenanthroline Derivatives and Cysteine Protease Inhibitor E64

机译:烷基和苄基-1,10-菲咯啉衍生物和半胱氨酸蛋白酶抑制剂E64的体外抗疟原虫作用

获取原文
           

摘要

Potential new targets for antimalarial chemotherapy include parasite proteases, which are required for several cellular functions during thePlasmodium falciparumlife cycle. Four new derivatives ofN-alkyl andN-benzyl-1,10-phenanthroline have been synthesized. Those are (1)-N-methyl-1,10-phenanthrolinium sulfate, (1)-N-ethyl-1,10-phenanthrolinium sulfate, (1)-N-benzyl-1,10-phenanthrolinium chloride, and (1)-N-benzyl-1,10-phenanthrolinium iodide. Those compounds had potential antiplasmodial activity with IC50values from 260.42 to 465.38 nM. Cysteine proteinase inhibitor E64 was used to investigate the mechanism of action ofN-alkyl andN-benzyl-1,10-phenanthroline derivatives. A modified fixed-ratio isobologram method was used to study thein vitrointeractions between the new compounds with either E64 or chloroquine. The interaction betweenN-alkyl andN-benzyl-1,10-phenanthroline derivatives and E64 was additive as well as their interactions with chloroquine were also additive. Antimalarial mechanism of chloroquine is mainly on the inhibition of hemozoin formation. As the interaction of chloroquine and E64 was additive, the results indicated that these new compounds had a mechanism of action by inhibitingPlasmodiumproteases.
机译:抗疟疾化疗的潜在新靶标包括寄生虫蛋白酶,这是恶性疟原虫生命周期中几种细胞功能所必需的。合成了N-烷基和N-苄基-1,10-菲咯啉的四种新衍生物。它们是(1)-N-甲基-1,10-菲咯啉鎓硫酸盐,(1)-N-乙基-1,10-菲咯啉鎓硫酸盐,(1)-N-苄基-1,10-菲咯啉鎓氯化物和(1 )-N-苄基-1,10-菲咯啉碘化物。这些化合物具有潜在的抗血浆活性,IC50值为260.42至465.38 nM。使用半胱氨酸蛋白酶抑制剂E64来研究N-烷基和N-苄基-1,10-菲咯啉衍生物的作用机理。一种改进的固定比率等效线图方法用于研究新化合物与E64或氯喹之间的体外相互作用。 N-烷基和N-苄基-1,10-菲咯啉衍生物与E64的相互作用是加和的,并且它们与氯喹的相互作用也是加和的。氯喹的抗疟机制主要是抑制血zo素的形成。由于氯喹和E64的相互作用是加和的,因此结果表明这些新化合物具有抑制疟原虫蛋白酶的作用机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号